Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06423664 · ClinicalTrials.gov registry record · NA

Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure

A NA study of Developmental Delay, sponsored by IDeA States Pediatric Clinical Trials Network.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
3
Study locations

NCT06423664 is a NA study of Developmental Delay that is actively recruiting participants, run by IDeA States Pediatric Clinical Trials Network. The registered enrollment target is 20 participants, below the 295-participant average among 10 other Developmental Delay trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06423664, a NA study of Developmental Delay, is actively recruiting participants, sponsored by IDeA States Pediatric Clinical Trials Network.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
3
Study locations

Study Summary

The INTACT trial is a multisite pilot feasibility study aimed at testing the effectiveness of the INTACT Intervention program in improving neurodevelopmental outcomes in infants prenatally exposed to cannabinoids. The trial will enroll 20 birthing parent/infant dyads across three sites and will evaluate feasibility endpoints rather than clinical outcomes. The study duration is 22 months, including study start-up, enrollment and intervention, and data analysis and manuscript preparation.

Conditions Studied

Developmental Delay

Interventions

  • BEHAVIORAL Play and Learn Strategies (PALS) Program

Study Locations (3)

New Mexico

  • University of New Mexico Health Sciences Center - Albuquerque

South Dakota

  • Avera Research Institute - Sioux Falls

Vermont

  • University of Vermont Medical Center - Burlington

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-02-06
Est. Completion 2026-08-31
Phase NA

Sponsor

IDeA States Pediatric Clinical Trials Network

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06423664

The ClinicalTrials.gov registry entry for NCT06423664 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 295-participant average among 10 other Developmental Delay trials with a reported enrollment target (93% lower). The listed sponsor is IDeA States Pediatric Clinical Trials Network, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Developmental Delay appearing as the primary indexed condition, and to 1 intervention - of which Play and Learn Strategies (PALS) Program is the first listed.

NCT06423664 reports 3 study locations spanning 3 distinct geographic areas - top geographies include New Mexico, South Dakota, Vermont.

Frequently Asked Questions

What is clinical trial NCT06423664 about?

NCT06423664 is a clinical study titled "Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure". The INTACT trial is a multisite pilot feasibility study aimed at testing the effectiveness of the INTACT Intervention program in improving neurodevelopmental outcomes in infants prenatally exposed to cannabinoids. The trial will enroll 20 birthing parent/infant dyads across three sites and will eval...

What is the current status of trial NCT06423664?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-02-06. Estimated completion is 2026-08-31.

What conditions does trial NCT06423664 study?

This clinical trial studies the following conditions: Developmental Delay.

What interventions are being tested in trial NCT06423664?

The interventions under investigation include: Play and Learn Strategies (PALS) Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06423664?

This trial is sponsored by IDeA States Pediatric Clinical Trials Network, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06423664 being conducted?

This trial has 3 study locations across New Mexico, South Dakota, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Developmental Delay

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Developmental Delay

All registered trials for this condition

New Mexico

All trials with a study site in New Mexico

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.